Please login to the form below

Not currently logged in
Email:
Password:

US Department of Justice

This page shows the latest US Department of Justice news and features for those working in and with pharma, biotech and healthcare.

US charges Teva for generic drug price-fixing plot

US charges Teva for generic drug price-fixing plot

Company maintains it has not committed any wrongdoing. The US Department of Justice (DoJ) has charged Teva Pharmaceuticals for conspiring with competitors in a generic drugs price-fixing probe. ... In May last year, a wide-ranging lawsuit was filed in

Latest news

  • Ex-Sandoz exec admits role in generic drug price-fixing plot Ex-Sandoz exec admits role in generic drug price-fixing plot

    Reignites criticism of high drug prices in the US. Former Sandoz executive Hector Armando Kellum has pled guilty to charges levied against him, which allege he participated in a price-fixing ... Although these two medicines were the only ones

  • Teva among generic drugmakers hoping to settle US antitrust probe Teva among generic drugmakers hoping to settle US antitrust probe

    Teva Pharmaceuticals is among one of a number of generic drugmakers allegedly looking to resolve a criminal antitrust probe initiated by the US Department of Justice, according to Bloomberg. ... Back in  August, US politicians also accused Teva,

  • Avanir’s week goes from bad to worse with Alzheimer’s stumble Avanir’s week goes from bad to worse with Alzheimer’s stumble

    The US Department of Justice said on Friday that Avanir had encouraged prescribing of Nuedexta for unapproved uses, including agitation in AD, and took advantage of a drive to reduce the ... Otsuka paid $3.5bn to  acquire Avanir in 2014 as part of a

  • Reckitt hammered by $1.4bn opioid settlement bill Reckitt hammered by $1.4bn opioid settlement bill

    The settlement is the largest recovery for opioid drug mis-marketing in US history, according to the Department of Justice, and is made up of $647m to the federal government, $700m ... to an epidemic of overdose deaths across the US in the last few years.

  • AZ’s Brilinta clears cardiovascular outcomes trial AZ’s Brilinta clears cardiovascular outcomes trial

    drug has a role in the longer-term prevention of cardiovascular events, helping to meet that objective. ... the US and elsewhere, which eventually escalated into a full-blown inquiry by the US Department of Justice (DoJ) into the conduct of the study.

More from news
Approximately 3 fully matching, plus 46 partially matching documents found.

Latest Intelligence

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    As prices in the US continue to spiral out of control, we can only look on with envy. ... Department of Justice.

  • As the opioid crisis grabs the headlines, the search for safe treatments continues As the opioid crisis grabs the headlines, the search for safe treatments continues

    Its share price took a massive hit when it was indicted by the US Justice Department earlier this year over its Suboxone Film therapy for opioid and heroin addiction, but its ... Pipeline provides hope. Indivior is fighting the Department of Justice

  • Cybersecurity Cybersecurity

    Generally the draft Regulation will not change this approach. One method of seeking to meet the adequacy requirement when transferring personal data to the US (which is not an approved country ... test). Following the decision in the Schrems case last

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics